http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115032311-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37a2cadcb4805e59e912ba10d60db29a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-54 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-54 |
| filingDate | 2022-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bb807133414cedc0cfd096a35597fac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_361ece9bd79a8ebb3763c6c9a2200f83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7e50d476ee0fa2fb09c7de0d0db936c |
| publicationDate | 2022-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-115032311-A |
| titleOfInvention | Determination method of Xinnaoxin drug components based on one-test-multiple-assessment method |
| abstract | The invention relates to a method for determining the content of Xinnaoxin medicinal components based on a method of one measurement and multiple evaluations. The relative correction factors of acid, caffeic acid, ethyl gallate and p-coumaric acid were calculated by the relative correction factors. : WondaSil C18‑WR chromatographic column; column temperature 28℃～35℃; mobile phase A is methanol; mobile phase B is 0.1% phosphoric acid solution; gradient elution is adopted; volume flow rate 1.0mL/min injection 20μL; detection wavelength 275nm ~290nm; the present invention performs quantitative analysis on Xinnaoxin medicine, and the obtained result is close to the external standard method, is simple, reliable, and has good repeatability, and provides a basis for the quality standard evaluation of Xinnaoxin medicine. |
| priorityDate | 2022-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.